newsfilter
← Latest News
GlobeNewswire·

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Data show that simufilam reduced seizure activity in a preclinical mouse model Presentation also highlights favorable human safety data from 1,929 patient Phase 3 program AUSTIN, Texas, June 30, 2025 (GLOBE NEWSWIRE)